Calibrate vs Found
Updated October 16, 2026
Employers adding obesity care and individuals paying for weight treatment themselves often hear about Calibrate and Found. The two now serve different buyers: Calibrate sells a coached program to employers and health plans, while Found sells a membership straight to the patient. Knowing who is paying settles most of the comparison before features come up.
Our analysts compared Calibrate and Found on buyer, medication billing, coaching, insurance options, and outcomes reporting, using the HIR review of each company and Calibrate's own announcements. In the following sections, we compare the services, show which buyer each suits, and note Calibrate's recent shift.
Calibrate vs Found at a glance, October 2026
| What buyers weigh | Calibrate | Found |
|---|---|---|
| Published price | Not published | Found posts promotional starting prices for membership and medication on joinfound.com. Confirm the total at checkout. |
| Pricing model | An obesity program with coaching, bought by employers and health plans. Medication is billed separately through pharmacy benefits. | A membership plus medication. Visits are cash-pay, with some insurance coverage depending on your plan and state. |
| What drives cost | The number of people covered, how much clinical care is included, how often coaching happens, the reports you want, and how much work with your pharmacy benefit manager is needed. | Which medication you take (brand-name or compounded), dose increases, membership length, and insurance coverage for visits. |
| What you need first | A signed contract with an employer or health plan. | A willingness to fill out an honest health history. |
| Deal-breaker | You are an individual who only wants compounded refills. | Your main treatment needs to be in-person procedures from a specialist. |
| Pricing clarity score | 7.0 | 7.3 Clearer pricing |
| HIR overall score | 7.3, Recommend. | 7.4, Recommend. |
| Best for | Employers and health plans that need an obesity program aimed at GLP-1 cost management with coaching and outcomes tracking. | Consumers who want clinician-guided weight care with insurance options where available. |
| Not a fit for | Individuals hunting the lowest cash-pay compounded tirzepatide refill. | Patients who need in-person specialty obesity medicine with local procedures. |
Which fits which buyer
Start with who signs the contract.
Choose Calibrate if
- You are an employer or health plan trying to control what you spend on weight medication.
- You want coaching and outcome reports for a covered population.
- You prefer medication billed through your pharmacy benefit.
Choose Found if
- You are an adult paying for your own weight care.
- You want clinician review online with insurance used where it applies.
- You want a choice between brand-name and compounded medication.
How they differ in practice
Calibrate sells physician-guided obesity programs mainly to employers and health plans, with coaching and outcome reporting, and bills medication through pharmacy benefits separately from the program fee.
Found is a direct-to-consumer telehealth path at joinfound.com: clinicians review patients online, membership plus medication is the commercial model, and pharmacy partners ship when a prescription is written.
Calibrate now sells mostly to employers after moving away from consumers. Found notes that compounded medications are not FDA-approved finished drugs.
Calibrate charges employers a per-employee monthly or program fee, and the health plan pays for the GLP-1 drugs. Found charges the patient a monthly membership plus the cost of medication at their dose.
Verdict
Calibrate is the right call for employers and plans that want a managed program. Found is the better fit for an individual who wants online weight care without waiting for an employer to offer it.
Patients who need in-person obesity medicine should look for a local specialist.
Where the two tools are headed in 2027 and beyond
Calibrate: Calibrate announced on February 19, 2026 that it had completed its move to selling mainly to employers, health plans, and channel partners.
Employers should ask for outcome data at twelve months, and patients should ask for the full monthly cost at their dose.
Methodology
Each row comes from the HIR reviews of Calibrate and Found, scored under the HIR method, and from each vendor's public pricing where it exists. Any published price for Calibrate or Found was checked on that vendor's own site on October 16, 2026.
A green check marks a clear edge for Calibrate or Found only where their review scores differ by at least 0.3 points or the two reviews show a plain difference. Rows with nothing published for either Calibrate or Found are left out, and time to full value for each adds up the rollout stages in its review.
Sources
- HIR review of Calibrate and HIR review of Found
- Calibrate website
- Found website
- Reddit discussions of Calibrate and Found, linked in the buyer section
- Calibrate completes enterprise transition, February 19, 2026